FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2261198346> ?p ?o ?g. }

• W2261198346 endingPage "804" @default.
• W2261198346 startingPage "798" @default.
• W2261198346 abstract "The present study investigated the in vitro effect of four different chemotherapeutic agents, namely, cyclophosphamide (CTX), vincristine (VCR), Adriamycin (Adria Laboratories, Columbus, Ohio) (ADR), and actinomycin D (ACT-D) on human polymorphonuclear leukocyte (PMN) function. Human PMNs suspended in phosphate-buffered saline (PBS) at 1 X 10(7) cells/mL were incubated with increasing concentrations of CTX (0, 10(-5), 10(-4), 10(-3) mol/L) or VCR (0, 10(-7), 10(-6), 10(-5), 10(-4) mol/L), ADR (0, 10(-6), 10(-5), 10(-4), 10(-3) mol/L), or ACT-D (0, 5 X 10(-8), 1 X 10(-7), 5 X 10(-7), and 10(-6) mol/L). The cells were then tested for bacterial killing against Staphylococcus aureus, chemotaxis activity stimulated by Escherichia coli endotoxin, N-formyl-methionyl-leucyl-phenylalanine (FMLP)-stimulated aggregation, and cytochalasin B (Cyto B)/FMLP-stimulated superoxide production and enzyme degranulation. High concentration of CTX, an alkylating agent, showed a significant depression of PMN superoxide production, (124 +/- 13 v 161 +/- 15 nmol/10(7) cells, 5 minutes, P less than or equal to .025). ADR, an intercalating agent and membrane inhibitor, showed a significant depression of PMN degranulation and lysozyme release at 10(-4) and 10(-3) mol/L (15.3% +/- 1.7% v 24% +/- 7%, P less than .01; and 15.0% +/- 2.5% v 24% +/- 7%, P less than or equal to .025). VCR, a microtubule inhibitor, showed a significant depression of PMN aggregation at 10(-6), 10(-5), and 10(-4) mol/L (P less than .05), lysozyme release at 10(-4) mol/L (P less than .004), and beta-glucuronidase release at 10(-4) mol/L (P less than .004). In addition, chemotaxis was inhibited by VCR in a dose-dependent manner at all concentrations (10(-7) mol/L, P less than .02; 10(-6) mol/L, P less than .007; 10(-5) mol/L, P less than .006, and 10(-4) mol/L, P less than .003). ACT-D showed no significant effect on the PMN functions tested. These studies conclude that chemotherapeutic agents have modulating in vitro effects on PMN function. Further in vivo studies are therefore needed to assess PMN abnormalities in patients receiving cancer chemotherapy to determine their role in infectious complications." @default.
• W2261198346 created "2016-06-24" @default.
• W2261198346 creator A5001697191 @default.
• W2261198346 creator A5008057825 @default.
• W2261198346 creator A5030370087 @default.
• W2261198346 creator A5041200670 @default.
• W2261198346 creator A5054267866 @default.
• W2261198346 creator A5058724994 @default.
• W2261198346 date "1986-05-01" @default.
• W2261198346 modified "2023-09-29" @default.
• W2261198346 title "Impaired in vitro polymorphonuclear function secondary to the chemotherapeutic effects of vincristine, adriamycin, cyclophosphamide, and actinomycin D." @default.
• W2261198346 cites W1761031520 @default.
• W2261198346 cites W1951104674 @default.
• W2261198346 cites W1998811550 @default.
• W2261198346 cites W2005408885 @default.
• W2261198346 cites W2028323201 @default.
• W2261198346 cites W2036068566 @default.
• W2261198346 cites W2061849723 @default.
• W2261198346 cites W2117966002 @default.
• W2261198346 cites W2151634273 @default.
• W2261198346 cites W2285064622 @default.
• W2261198346 cites W2410630997 @default.
• W2261198346 cites W2411536170 @default.
• W2261198346 cites W2418018640 @default.
• W2261198346 cites W2419492843 @default.
• W2261198346 cites W1917384387 @default.
• W2261198346 cites W2017031849 @default.
• W2261198346 doi "https://doi.org/10.1200/jco.1986.4.5.798" @default.
• W2261198346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3009727" @default.
• W2261198346 hasPublicationYear "1986" @default.
• W2261198346 type Work @default.
• W2261198346 sameAs 2261198346 @default.
• W2261198346 citedByCount "22" @default.
• W2261198346 countsByYear W22611983462014 @default.
• W2261198346 countsByYear W22611983462023 @default.
• W2261198346 crossrefType "journal-article" @default.
• W2261198346 hasAuthorship W2261198346A5001697191 @default.
• W2261198346 hasAuthorship W2261198346A5008057825 @default.
• W2261198346 hasAuthorship W2261198346A5030370087 @default.
• W2261198346 hasAuthorship W2261198346A5041200670 @default.
• W2261198346 hasAuthorship W2261198346A5054267866 @default.
• W2261198346 hasAuthorship W2261198346A5058724994 @default.
• W2261198346 hasConcept C126322002 @default.
• W2261198346 hasConcept C153911025 @default.
• W2261198346 hasConcept C170493617 @default.
• W2261198346 hasConcept C181199279 @default.
• W2261198346 hasConcept C185592680 @default.
• W2261198346 hasConcept C202751555 @default.
• W2261198346 hasConcept C2776694085 @default.
• W2261198346 hasConcept C2776755627 @default.
• W2261198346 hasConcept C2776966407 @default.
• W2261198346 hasConcept C2779012151 @default.
• W2261198346 hasConcept C2779429289 @default.
• W2261198346 hasConcept C2780795997 @default.
• W2261198346 hasConcept C2781021840 @default.
• W2261198346 hasConcept C49802076 @default.
• W2261198346 hasConcept C54166955 @default.
• W2261198346 hasConcept C55493867 @default.
• W2261198346 hasConcept C71924100 @default.
• W2261198346 hasConcept C86803240 @default.
• W2261198346 hasConcept C98274493 @default.
• W2261198346 hasConceptScore W2261198346C126322002 @default.
• W2261198346 hasConceptScore W2261198346C153911025 @default.
• W2261198346 hasConceptScore W2261198346C170493617 @default.
• W2261198346 hasConceptScore W2261198346C181199279 @default.
• W2261198346 hasConceptScore W2261198346C185592680 @default.
• W2261198346 hasConceptScore W2261198346C202751555 @default.
• W2261198346 hasConceptScore W2261198346C2776694085 @default.
• W2261198346 hasConceptScore W2261198346C2776755627 @default.
• W2261198346 hasConceptScore W2261198346C2776966407 @default.
• W2261198346 hasConceptScore W2261198346C2779012151 @default.
• W2261198346 hasConceptScore W2261198346C2779429289 @default.
• W2261198346 hasConceptScore W2261198346C2780795997 @default.
• W2261198346 hasConceptScore W2261198346C2781021840 @default.
• W2261198346 hasConceptScore W2261198346C49802076 @default.
• W2261198346 hasConceptScore W2261198346C54166955 @default.
• W2261198346 hasConceptScore W2261198346C55493867 @default.
• W2261198346 hasConceptScore W2261198346C71924100 @default.
• W2261198346 hasConceptScore W2261198346C86803240 @default.
• W2261198346 hasConceptScore W2261198346C98274493 @default.
• W2261198346 hasIssue "5" @default.
• W2261198346 hasLocation W22611983461 @default.
• W2261198346 hasLocation W22611983462 @default.
• W2261198346 hasOpenAccess W2261198346 @default.
• W2261198346 hasPrimaryLocation W22611983461 @default.
• W2261198346 hasRelatedWork W2003922521 @default.
• W2261198346 hasRelatedWork W2004895474 @default.
• W2261198346 hasRelatedWork W2016079682 @default.
• W2261198346 hasRelatedWork W203248025 @default.
• W2261198346 hasRelatedWork W2075635704 @default.
• W2261198346 hasRelatedWork W2079746485 @default.
• W2261198346 hasRelatedWork W2135404678 @default.
• W2261198346 hasRelatedWork W2163993168 @default.
• W2261198346 hasRelatedWork W2414074028 @default.
• W2261198346 hasRelatedWork W3030725369 @default.
• W2261198346 hasVolume "4" @default.
• W2261198346 isParatext "false" @default.
• W2261198346 isRetracted "false" @default.

• next